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Abstract
Background: Over the last decade, our group has demonstrated that murine preconception immunization with
allergens has a protective effect on allergy development in offspring. The murine model used in the present study
allowed us to compare allergy induction by ovalbumin (OVA) and dust mite extract from Dermatophagoides
pteronyssinus (Dp).
Findings: Female mice were immunized with OVA or Dp. Pups from immunized and non-immune mothers were
immunized at 3 days old (do) with the same antigen used for the maternal immunization. The offspring were
analyzed at 20 do. Preconceptional immunization with OVA or Dp did not increase maternal IgE serum levels,
although the immunizations induced an increase in allergen-specific IgG1 Ab levels. Offspring serum analyses
revealed that maternal immunization with OVA suppressed IgE production only in offspring immunized with
OVA. Both preconception immunization protocols inhibited cellular influx into the airways of immunized offspring
compared with controls. Similar frequencies of offspring IgM + B cells were found in the OVA- and Dp-immunized
groups compared with their respective control groups. Moreover, preconception immunization with OVA enhanced
FcγRIIb expression on OVA-immunized offspring B cells. In contrast, decreased FcγRIIb expression was detected on
Dp-immunized offspring B cells compared with cells from the offspring of non-immune mothers.
Conclusions: Together, these results show that preconception OVA immunization and Dp immunization can inhibit
allergy development but have opposite effects on FcγRIIb expression on offspring B cells.
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Introduction
In an earlier study, we showed that preconception
immunization with the mite Dermatophagoides ptero-
nyssinus (Dp) could suppress anaphylactic IgE produc-
tion and regulate Th2 cytokine exacerbation in offspring
[1]. Subsequently, we observed that preconception
immunization with ovalbumin (OVA) could induce the
passive transference of maternal anti-OVA IgG1 anti-
bodies (Abs) at high levels [2], which could be detected
in the sera of offspring concomitant with the increased
expression of inhibitory FcγRIIb receptors on B cells [3].
Co-localizing with B cell receptors (BCRs), FcγRIIb recep-
tors can interact with IgG/antigen immune complexes and
phosphorylate the inhibitory phosphatase SHIP, leading to
the inhibition of B cell activation [4]. This process hinders
formation of the immunological synapse between B cells
and CD4+ T cells, which is necessary for isotype switching
and IgE production [5].
Our hypothesis was that maternal antibodies (MatAbs)
transferred during pregnancy and breastfeeding can
form immune complexes with allergens from offspring
and inhibit the activation of offspring B cells. In humans,
the increased passive transfer of anti-Dp MatAbs does not
have a protective effect on offspring [6]. Although OVA is
more widely used in murine models of type I hypersensitiv-
ity, Dp is an important commonly inhaled allergen that
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causes bronchial asthma and allergic rhinitis in humans [7].
To date, the effect of maternal immunization with Dp
on the expression of inhibitory receptors in offspring B
cells has not been evaluated. In this study, we use a
murine model to compare the effects of OVA and Dp
immunization to better understand neonatal allergy
regulation and to guide future studies of allergy regula-
tion in humans.
Methods
Mice
Male and female C57BL/6 inbred mice were used at 8 to
10 weeks of age. Animals were purchased from the
Central Animal Facility of the School of Medicine,
University of Sao Paulo. Offspring were used during
the neonatal period (3 days old (do)). All experiments de-
scribed n this manuscript were approved by the University
of Sao Paulo – School of Medicine - Animal Ethics Com-
mittee (CEP-FMUSP: 097/11 - Sao Paulo, SP, Brazil).
Immunization protocols
Female mice were immunized subcutaneously with 1500
μg OVA (Sigma, USA) or 10 μg Dp (Indoor Biotechnolo-
gies, USA) in 6 mg Alum (FURP, Sao Paulo) and boosted
after 10 and 20 days with 1000 μg OVA or 10 μg Dp in
saline intraperitoneally (i.p.). Females were mated at 21
days post immunization. The pups of immunized and
non-immune mothers were immunized with the same
antigen used for maternal immunization. Offspring at 3 do
were immunized (i.p.) with 100 μg OVA or 10 μg Dp in 0.6
mg Alum and boosted after 10 days with the same antigen/
dose in saline. Sera from the mothers were obtained at
term. Experimental analyses of the offspring were per-
formed at 20 do. As a control group, non-immunized off-
spring from non-immune mothers were bled at 20 do, and
the sera were analyzed for total IgE production.
Determination of total IgE and anti-OVA/Dp IgG1 Ab levels
OVA- and Dp-specific IgG1 and total IgE antibodies
were measured by ELISA, as previously described [2].
To measure total IgE, a standard curve was used (Phar-
mingen, USA). The anti-OVA and anti-Dp Ab levels are
expressed as optical densities.
Lung inflammation
Offspring from either immune or non-immune mothers
were immunized and subjected to nasal instillations with
100 μg OVA or 10 μg Dp at 43, 50, 57, 58 and 59 do.
Bronchoalveolar fluid (BAL) was analyzed at 60 do fol-
lowing exsanguination of the abdominal aorta. The BAL
was obtained by washing the lungs with three times with
1.5 mL PBS using a tracheal tube, which was then
centrifuged at 800 rpm for 10 min. The cell pellet was
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Figure 1 Decreased pulmonary inflammation in offspring in response to preconception OVA or Dp immunization. Female mice were
immunized with OVA or Dp, boosted 10 and 20 days later, and mated on day 21. Sera from full-term pregnancies were evaluated for (A) total
IgE, (B) anti-OVA IgG1 and (C) anti-Dp IgG1 Ab levels by ELISA. Sera from full-term pregnancies of non-immune females were assessed as controls.
Offspring at 3 do were immunized with the same antigen used for the maternal immunizations, boosted at 13 do, and bled at 20 do. The offspring of
control non-immune mothers were immunized with OVA or Dp as controls. Total IgE levels were determined by ELISA, and the dashed line represents
IgE levels in control non-immunized 20 do offspring from nom-immune mothers (D). At 43 do, the offspring received five intranasal challenges with
OVA or Dp. After 24 h, BAL was assessed, and total cell counts were evaluated (E). The data are presented as mean (8 to 10 mice per group) ± SEM
values. *P≤ 0.05 compared with the control group.
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diluted in 300 μL PBS, and total leukocyte counts were
performed using a Neubauer chamber.
Spleen cell suspension
Spleens were collected, and cells were harvested for flow
cytometric analysis, as previously described [3].
Flow cytometry
For surface staining, a single-cell suspension in PBS +
1% BSA was incubated with the following fluorescent-
conjugated Abs (BD Biosciences, USA): anti-CD19,
anti-CD40, anti-IgM or anti-CD16/32. Gating of the
cells was based on specific isotype control values. Data
were acquired using an LSRFortessa cytometer (BD
Biosciences, USA) and analyzed with the FlowJo soft-
ware program (Tree Star, USA).
Statistical analysis
Differences between groups were considered significant
when P values were < 0.05 according to the Mann–
Whitney test.
Findings
First, we assessed maternal serum Ab levels at full-term
pregnancy after preconception immunization with OVA
or Dp. Preconception immunization with OVA or Dp
did not increase serum IgE levels (Figure 1A), although
the immunizations did increase the levels of allergen-
specific IgG1 Abs (Figures 1B-C). All immunized groups
produced higher levels of total IgE compared with con-
trol non-immune offspring from non-immune mothers
(Figure 1D). Analysis of the sera from the immunized off-
spring revealed that maternal immunization with OVA sup-
pressed IgE production only in offspring immunized with
OVA (Figure 1D) but not with Dp (Figure 1D).
Moreover, we evaluated the effect of maternal allergen
immunization on pulmonary inflammation in offspring,
and we verified that both preconception immunization
protocols inhibited cellular influx into the airways of im-
munized offspring compared with offspring from non-
immune mothers (Figure 1E).
To verify the effect of maternal immunization on off-
spring B cells, we evaluated CD40 and FcγRIIb expres-
sion on these cells. We observed that both maternal
immunization protocols could upregulate CD40 expres-
sion on offspring B cells compared with B cells from the
control offspring groups (Figure 2A). Similar frequencies
of offspring IgM + B cells were found in the OVA- and
Dp-immunized groups compared with their respective
control groups (Figure 2B). Moreover, preconception
immunization with OVA enhanced FcγRIIb expression
on OVA-immunized offspring B cells compared with B
Figure 2 Increased CD40 expression on offspring B cells induced by maternal immunization. Offspring from (A) OVA- or (B) Dp-immunized
mothers were immunized at 3 do with the same antigen used in the maternal immunization and boosted at 13 do. At 20 do, splenic CD19+ B cells were
assessed for CD40 expression and the percentage of CD19+ IgM+ cells. The control group was composed of offspring from non-immune mothers
immunized with OVA or Dp. Representative histograms of CD40 expression for each group are shown (A-B, middle panels). The data are presented as
mean (8 to 10 mice per group) ± SEM values. *P≤ 0.05 compared with the control group.
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cells from OVA-immunized offspring from non-immune
mothers (Figure 3A). In contrast, decreased FcγRIIb ex-
pression was observed on Dp-immunized offspring B
cells compared with B cells from the Dp-immunized off-
spring control group (Figure 3B).
Discussion
By varying the allergen dose in the maternal immunization
protocol from 1 to 10 μg Dp, we were able to detect an
increase in the maternal Ab response and passive Ab
transference in the highest titers (10 μg) (data not
shown). This dose could also inhibit the allergic re-
sponse and lung inflammation in offspring and was
therefore adopted as the standard dose.
Neither preconception immunization protocol induced
higher total IgE levels, suggesting that the females did
not reach allergic status and that both protocols could
sensitize the maternal immune system. As we previously
described, MatAbs are passively transferred to their off-
spring, concomitant with anaphylactic IgE suppression in
offspring [1-3]. Preconception OVA immunization could
reduce total IgE production in offspring, in contrast with
maternal Dp immunization. However, both protocols could
downregulate pulmonary inflammation in offspring, sug-
gesting that allergy development in the offspring was inhib-
ited by preconception OVA or Dp immunization.
Phenotypic analysis of offspring B cells revealed an
equivalent increase in CD40 expression on offspring B
cells from both types of immune mothers. However, this
status could not have influenced isotype switching of the
offspring B cells in response to neonatal immunization,
as the percentages of IgM + B cells were similar between
pups from OVA- or DP-immunized mothers compared
with those from non-immune mothers.
Maternal OVA immunization can induce the upregula-
tion of FcγRIIb receptors on offspring B cells at 20 do,
as described previously by our group [3]. The inhibitory
co-receptor FcγRIIb can inhibit the in vitro activation of
B cells [4,8,9] and induce apoptosis in plasma cells [10].
Therefore, the upregulation of FcγRIIb levels on B cells
in the presence of immune complexes may represent an
effective way to downregulate immune activation. We de-
tected the overexpression of FcγRIIb on offspring IgM+B
cells, which consisted primarily of naïve B cells. This result
is consistent with our hypothesis that passively transferred
MatAbs can negatively regulate offspring B cells by inter-
acting with allergens in the offspring and inhibiting off-
spring B cell activation and isotype switching, thereby
downregulating IgE production and allergy develop-
ment. Our results demonstrate that this effect cannot be
induced by maternal Dp immunization, for which an
opposite effect was observed, with offspring B cells
Figure 3 The maternal antigen immunization protocols yield opposing results with respect to FcγRIIb expression on offspring B cells.
Offspring from (A) OVA- or (B) Dp-immunized mothers were immunized at 3 do with the same antigen used for the maternal immunization and
boosted at 13 do. At 20 do, splenic CD19+ B cells were evaluated for FcγRIIb expression. The control group was composed of offspring from
non-immune mothers immunized with OVA or Dp. Representative histograms of FcγRIIb expression in each group are shown on the right side of
the respective graph. The data are presented as mean (8 to 10 mice per group) ± SEM values. *P≤ 0.05 compared with the control group.
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showing downregulated FcγRIIb expression in response
to maternal Dp immunization.
Our findings suggest that maternal Dp immunization
does control offspring allergy development but without
the upregulation of FcγRIIb on offspring B cells, as ob-
served in the maternal OVA immunization protocol [3].
This phenomenon could be due to the fact that the Dp
extract contains a variety of proteins with biological ac-
tivity, in contrast with purified OVA. The main antigenic
fraction of Dp (Der p 1) is a 25 kDa cysteine protease.
Recombinant Der p 1 and natural Der p 1 have similar
biological effects on immune cells [11]. These effects in-
clude the optimization of antigen capture and processing
by APCs [12], as well as the cleavage of CD23 on B cells
[13,14] and of CD25 on T cells [15]. This activity blocks
the negative feedback mediated by IgE Abs that interact
with B cells via CD23 and the induction of low IFN-γ and
high IL-4 production due to CD25 cleavage on CD4+ T
cells [16].
The regulation of FcγRIIb expression on B cells in re-
sponse to CD23 activity has not been described, although
it is possible that Dp antigenic activity may indirectly
influence FcγRIIb expression. The fact that maternal Dp
immunization can inhibit pulmonary inflammation in off-
spring, independent of FcγRIIb upregulation on offspring B
cells, may be due to other mechanisms, such as allergen
neutralization and idiotypic interactions [17] or the induc-
tion of offspring regulatory T cells [18]. In any case, the ac-
tivity of these mechanisms appears to result in a similar
mode of regulation in offspring until 20 do in mice, as we
show in this report. Future studies on preconception Dp
immunization should examine purified Dp proteins with
similar structural and biological activities as the Dp extract.
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